Global standards for AI-designed proteins for rapidly urbanizing regions
open
India, Asia
WS04686
AI-designed biological molecules may be created faster than their safety, ecological, and clinical properties can be characterized. The open problem is building evaluation pipelines proportionate to capability and deployment risk. The approach must scale before formal institutions, infrastructure, and land-use systems fully catch up with population growth. The research opportunity is to define measurable success criteria, test the approach in realistic settings, identify failure modes, and create a pathway from prototype to accountable deployment.